mpower and jq1234,
Excellent posts. It doesn't appear that this jmkobers person is looking for honest answers or has honest questions. Obviously the MNTA stock price was driven down by the 3 events, 1) Sanofi lawsuit, 2) the spreading of "information" that some insiders made some sales after approval, and 3) a comment by an analyst that Teva will get approval for their generic.
Numbers 1) and 3) are the most serious is they came to pass. For #1, the judge refused to grant an injunction so the cash is rolling in for MNTA. It is fine with me if the judge takes his sweet time, as long as the ruling ultimately goes against Sanofi. While there are no guarantees, from what I read it certainly looks promising for MNTA. For #3, it smells like the typical rumor spreading that makes people hate Wall Street analysts and Wall Street.
The 2nd point is the old insiders are selling crap that burned shorts like to spread. What, insiders can never sell because whenever they do it must mean they know something bad is coming. One needs to look at how much was sold, what percentage of the total shares held were sold, and why they were sold.